drugset / Trial / NCT01457664
A Study of RO4995819 in Healthy Elderly Volunteers
RandomizedSingle-groupDouble-blindTreatment
Summary
This study will evaluate the safety, tolerability and pharmacokinetics of RO4995819 in healthy elderly volunteers. Volunteers will be randomized to receive once daily doses of RO4995819 or matching placebo. The anticipated time on study treatment is 14 days.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO4995819 | Small molecule | — | Oral |
Indications
No indication recorded.